Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study

Moreau, Philippe, Pylypenko, Halyna, Grosicki, Sebastian · The Lancet Oncology · 2011